Pfizer to Split into Generic and Branded Drugs Units

Pfizer Inc, the largest U.S. drugmaker, said it plans to separate its commercial operations into two units, mainly for patent-protected brands, and a third for generics.

 Earlier this year, Pfizer said it would begin examining the finances of its patent-protected unit, which it calls its "innovative" business, and its generic operation, called its "value" business, to decide whether to spin off the generics operation. It said the review would take three years. Read more

More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments